The lawsuit was originally filed by former employees of AstraZeneca who acted as whistle-blowers and received a combined $1.4 million. While this is a public health issue, it is also an issue within the pharmaceutical industry due to profitability targets.
“Pharmaceutical companies that pay kickbacks in order to boost profits will be held accountable for their improper conduct,” said Special Agent in Charge Nick DiGiulio in the press release.
The announcement gave the Health Care Fraud Prevention and Enforcement Action Team (HEAT) credit for the settlement and partnership between the two departments which was formally established in 2009. Since January 2009, according to the press release, the Justice Department has recovered more than $23.6 billion through False Claims Act cases, with $15.1 billion involving financial fraud against federal health care programs.